Skip to main content
Log in

NICE updates draft guidance on two lung cancer drugs

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. see PharmacoEconomics & Outcomes News 696 p9-10; 801085795

  2. epidermal growth factor receptor-tyrosine kinase

Reference

  • NICE. NICE consults again on updated guidance for two lung cancer drugs. Media Release : 6 Aug 2014. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE updates draft guidance on two lung cancer drugs. PharmacoEcon Outcomes News 709, 11 (2014). https://doi.org/10.1007/s40274-014-1472-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1472-0

Navigation